Chemopreventive strategies are very attractive and have earned serious consideration as a potential means of controlling cancer incidence. However, the use of some anti-initiating entities (enzyme inducers or inhibitors) devised to reduce tumor initiation is controversial. Indeed, considering the double-edged-sword (activating or detoxifying) nature of drug metabolizing enzymes, any attempt to modulate such catalysts by dietary components (including drugs) may lead to cancer risk.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1525-1500.1998.00088.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!